The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $76.10

Today's change+1.04 +1.39%
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $76.10

Today's change+1.04 +1.39%
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc up (U.S.)$1.04

DaVita HealthCare Partners Inc closed up Wednesday by (U.S.)$1.04 or 1.39% to (U.S.)$76.10. Over the last five days, shares have gained 1.30% and are currently 3.08% off of the 52-week high. Shares have outperformed the S&P 500 by 10.92% during the last year.

Key company metrics

  • Open(U.S.) $75.23
  • Previous close(U.S.) $75.06
  • High(U.S.) $76.44
  • Low(U.S.) $75.09
  • Bid / Ask-- / --
  • YTD % change+20.09%
  • Volume1,255,929
  • Average volume (10-day)1,751,760
  • Average volume (1-month)1,732,634
  • Average volume (3-month)1,161,465
  • 52-week range(U.S.) $56.85 to (U.S.) $78.52
  • Beta0.63
  • Trailing P/E22.62×
  • P/E 1 year forward21.18×
  • Forward PEG5.03×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.36
Updated November 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.84%

Based on its net profit margin of 6.84%, DaVita HealthCare Partners Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue3,2523,1723,0433,063
Total other revenue--------
Total revenue3,2523,1723,0433,063
Gross profit925926863935
Total cost of revenue2,3272,2472,1802,128
Total operating expense2,8142,6882,6022,579
Selling / general / administrative327302287320
Research & development--------
Depreciation / amortization149146143139
Interest expense (income), net operating--------
Unusual expense (income)17000
Other operating expenses, total--------
Operating income438484441484
Interest income (expense), net non-operating-98-195-106-108
Gain (loss) on sale of assets--------
Other--------
Income before tax336282337380
Income after tax220181212244
Income tax, total117101125136
Net income184148183212
Total adjustments to net income00--0
Net income before extra. items184148183212
Minority interest-36-34-28-32
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items184148183212
Inc. avail. to common incl. extra. items184148183212
Diluted net income184148183212
Dilution adjustment----00
Diluted weighted average shares217217216215
Diluted EPS excluding extraordinary itemsvalue per share0.850.680.850.99
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.900.680.850.99